Stephen Karpen

Senior Director, Regulatory Affairs, Breakthrough T1D

About this speaker

Stephen Karpen, PharmD is the Senior Director for Regulatory Affairs. Dr. Karpen is responsible for implementing Breakthrough T1D’s regulatory strategy and works to accelerate the development of T1D therapies by developing solutions to challenges faced by researchers, sponsors, and regulators. Prior to joining Breakthrough T1D, Dr. Karpen was the Senior Scientific Director for the Critical Path Institute’s Type 1 Diabetes Consortium and established the Institute’s Regulatory Science Program. Dr. Karpen received his Doctor of Pharmacy from the University of Arizona College of Pharmacy and is a Professor of Practice with the University of Arizona James E. Rogers College of Law. An Arizona native, Dr. Karpen now lives in Denver, Colorado with his wonderful wife Jaci, and their two pups, Brown Dog and Scout.

Talks

Session Three-Four Panel Discussion: C-Peptide as Biomarker in Trials of T1D

18 June 2025, 04:45 PM
Helen Colhoun Stephen Karpen Joseph Hedrick Colin Mark Dayan Kimberly Collins Peter Senior Christoph Tasto Justin Penzenstadler, PharmD

Panel Discussion: The Big Picture, Where Do We Stand and What's Next?

18 June 2025, 06:00 PM
Matthias von Herrath Stephen Karpen Jeffrey Siegel Joseph Hedrick Elisabeth Niemoeller John Sharretts, MD Jason Gaglia, MD, MMSc